Observation on the therapeutic effect of surgery+radiotherapy combined with injection of triamcinolone acetonide in the treatment of auricular scar

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400087126

Enrollment

Unknown

Registered

2024-07-19

Start date

2024-07-23

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

auricular scar

Interventions

Triamcinolone group:None

Non-triamcinolone group:None

Eligibility

Sex/Gender

All

Age

14 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age range from 14 to 70 years old; 2. Perform auricular scar excision surgery and postoperative radiotherapy.

Exclusion criteria

Exclusion criteria: 1.Severe diseases such as heart, lung, liver, and kidney are complicated; 2. Not cooperating with this study

Design outcomes

Primary

Measure	Time frame
Vancouver Scar Rating Scale;	—

Countries

CHINA

Contacts

Public ContactJingyan Wang

Affiliated Hospital Of Hebei University

844108222@qq.com+86 183 3209 6223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026